CTX0E03
Published 9th February 2019, updated 9th February 2019
Unassigned
New Medicines
Disability following acute stroke
Information
Cell-based therapy (not an ATMP)
ReNeuron
ReNeuron
Development and Regulatory status
Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Category
Neural stem cells
Approximately 150,000 people suffer a stroke in the UK each year. Around one half of survivors are left with permanent disabilities as a result of the damage caused to brain tissue arising from the stroke. Beyond the acute phase, there are only preventative or rehabilitation measures [1]. ·
Disability following acute stroke
Stereotactic
Parenteral